Resources Contact Us Home
Modified leukotoxin protein

Image Number 10 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Motor and disk drive apparatus
LED string with a capability to maintain a current path and LED unit thereof
Bioreactor device, and method and system for fabricating tissues in the bioreactor device
Systems and methods for simultaneously configuring multiple independent backups
Manufacturing process for cellular screening substratum, resultant substratum, and method and apparatus for screening
Antibodies to OX-2/CD200 and uses thereof
Active matrix substrate, method for manufacturing same, and liquid crystal display apparatus
  Randomly Featured Patents
Alignment layer for liquid crystals
Fuel additive compositions containing poly(oxyalkylene) hydroxyaromatic esters and poly(oxyalkylene) amines
Beam shaping optical system
Adjustable bandwidth high pass filter for large input signal, low supply voltage applications
Fluid collection self-locking, self-blunting safety needle system and syringe
Method and system for detecting hidden edges
Methods and apparatus for providing a cooperative relay system associated with a broadband wireless access network
Over-center latch for a utility box
Gallium nitride-based compound semiconductor light-emitting device
Aging circuit for organic electro luminescence device and driving method thereof